6 employees
Engage Bio transforms cancer cells into factories for immunotherapies.
2021
$3.9M
from 6 investors over 6 rounds
Engage Bio raised $3.9M on May 1, 2022
Investors: WorldQuant Ventures LLC, Y Combinator, Pioneer Fund, SAV (Scale Asia Ventures), California Innovation Fund and SciFounders